BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Moodys
US Army
Healthtrust
Chinese Patent Office
Colorcon
Citi
McKesson
Johnson and Johnson
Dow

Generated: January 19, 2018

DrugPatentWatch Database Preview

ZAROXOLYN Drug Profile

« Back to Dashboard

Which patents cover Zaroxolyn, and what generic alternatives are available?

Zaroxolyn is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in ZAROXOLYN is metolazone. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Drug patent expirations by year for ZAROXOLYN
Pharmacology for ZAROXOLYN
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for ZAROXOLYN

US Patents and Regulatory Information for ZAROXOLYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc ZAROXOLYN metolazone TABLET;ORAL 017386-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc ZAROXOLYN metolazone TABLET;ORAL 017386-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc ZAROXOLYN metolazone TABLET;ORAL 017386-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
Moodys
Teva
QuintilesIMS
Baxter
Harvard Business School
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot